BR0115865A - Derivados de piperazina 1,4-di-substituìda utilizáveis como bloqueadores de receptores adrenérgicos alfa1 uro-seletivos - Google Patents

Derivados de piperazina 1,4-di-substituìda utilizáveis como bloqueadores de receptores adrenérgicos alfa1 uro-seletivos

Info

Publication number
BR0115865A
BR0115865A BR0115865-1A BR0115865A BR0115865A BR 0115865 A BR0115865 A BR 0115865A BR 0115865 A BR0115865 A BR 0115865A BR 0115865 A BR0115865 A BR 0115865A
Authority
BR
Brazil
Prior art keywords
compounds
adrenergic receptor
piperazine derivatives
alpha
receptor blockers
Prior art date
Application number
BR0115865-1A
Other languages
English (en)
Inventor
Nitya Anand
Sanjay Jain
Neelima Sinha
Anita Chugh
Laxminarayan G Hegde
Jang Bahadur Gupta
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Publication of BR0115865A publication Critical patent/BR0115865A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)

Abstract

"DERIVADOS DE PIPERAZINA 1,4-DI-SUBSTITUìDA UTILIZáVEIS COMO BLOQUEADORES DE RECEPTORES ADRENéRGICOS ALFA~ 1~, URO-SELETIVOS". A presente invenção se relaciona a novos derivados de piperazina 1,4-di-substituída de Fórmula I e seus sais ácidos de adição farmaceuticamente aceitáveis tendo excelente atividade antagonista de receptores adrenérgicos a, uro-seletivos, atividade essa que excede a dos compostos previamente descritos. Os compostos da presente invenção representam um grande aperfeiçoamento no tratamento de sintomas de hiperplasia benigna da próstata (BPH). A invenção também se relaciona a métodos para produzir os novos compostos, composições farmacêuticas contendo os compostos e método de tratamento de sintomas de hiperplasia benigna da próstata usando os compostos.
BR0115865-1A 2000-11-30 2001-11-29 Derivados de piperazina 1,4-di-substituìda utilizáveis como bloqueadores de receptores adrenérgicos alfa1 uro-seletivos BR0115865A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1097DE2000 2000-11-30
PCT/IB2001/002261 WO2002044151A1 (en) 2000-11-30 2001-11-29 1,4-disubstituted piperazine derivatives useful as uro-selective $g(a)1-adrenoceptor blockers

Publications (1)

Publication Number Publication Date
BR0115865A true BR0115865A (pt) 2003-12-23

Family

ID=11097130

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0115865-1A BR0115865A (pt) 2000-11-30 2001-11-29 Derivados de piperazina 1,4-di-substituìda utilizáveis como bloqueadores de receptores adrenérgicos alfa1 uro-seletivos

Country Status (25)

Country Link
US (1) US6914064B2 (pt)
EP (1) EP1339682A1 (pt)
JP (1) JP2004514711A (pt)
KR (1) KR20030068164A (pt)
CN (1) CN1230423C (pt)
AP (1) AP2003002810A0 (pt)
AR (1) AR035930A1 (pt)
AU (2) AU2231502A (pt)
BG (1) BG107943A (pt)
BR (1) BR0115865A (pt)
CA (1) CA2430343A1 (pt)
CZ (1) CZ20031698A3 (pt)
DO (1) DOP2001000296A (pt)
EA (1) EA006941B1 (pt)
EE (1) EE200300250A (pt)
HU (1) HUP0400545A3 (pt)
MA (1) MA26064A1 (pt)
MX (1) MXPA03004850A (pt)
NZ (1) NZ526226A (pt)
OA (1) OA12537A (pt)
PA (1) PA8534001A1 (pt)
PL (1) PL362210A1 (pt)
SK (1) SK8052003A3 (pt)
WO (1) WO2002044151A1 (pt)
ZA (1) ZA200304242B (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2481888A1 (en) * 2002-04-08 2003-10-16 Ranbaxy Laboratories Limited Alpha, omega-dicarboximide derivatives as useful uro-selective a1a adrenoceptor blockers
WO2005037281A1 (en) * 2003-10-15 2005-04-28 Ranbaxy Laboratories Limited 1-alkylpiperazinyl-pyrrolidin-2, 5-dione derivatives as adrenergic receptor antagonist
WO2005092341A1 (en) * 2004-03-22 2005-10-06 Ranbaxy Laboratories Limited Combination therapy for lower urinary tract symptoms
WO2005113498A1 (en) * 2004-05-19 2005-12-01 Ranbaxy Laboratories Limited Adrenergic receptor antagonists
US20090312344A1 (en) * 2004-05-31 2009-12-17 Mohammad Salman Arylpiperazine derivatives as adrenergic receptor antagonists
WO2006018815A1 (en) * 2004-08-16 2006-02-23 Ranbaxy Laboratories Limited Piperazine derivatives as adrenergic receptor antagonists
WO2006051399A1 (en) * 2004-11-11 2006-05-18 Ranbaxy Laboratories Limited Piperazine derivatives useful as adrenergic receptor antagonists
WO2006051374A2 (en) * 2004-11-11 2006-05-18 Ranbaxy Laboratories Limited Arylpiperazines useful as adrenergic receptor antagonists
WO2006092710A1 (en) * 2005-03-02 2006-09-08 Ranbaxy Laboratories Limited Metabolites of 2-{3-[4-(2-isopropoxyphenyl) piperazin-1-yl]-propyl}-3a,4,7,7a-tetrahydro-1h-isoindole-1,3-(2h)-dione
WO2006117760A1 (en) * 2005-05-03 2006-11-09 Ranbaxy Laboratories Limited Adrenergic receptor antagonists
WO2007029156A2 (en) * 2005-09-05 2007-03-15 Ranbaxy Laboratories Limited Isoindoledione derivatives as adrenergic receptor antagonists
WO2007039809A1 (en) * 2005-10-05 2007-04-12 Ranbaxy Laboratories Limited Metabolites of 2- {3-[4-(5-fluoro-2-isopropoxy-phenyl)-piperazin-1-yl]-propyl} -5,6-dihydroxy-hexahydro-isoindole-1,3-dione
US9227944B2 (en) 2008-10-10 2016-01-05 Institute Of Pharmacology And Toxicology Academy Of Military Science P.L.A. China Dopamine D3 receptor ligands and preparation and medical uses of the same
US8829001B2 (en) 2008-10-10 2014-09-09 The Institute of Pharmacology and Toxicology Academy of Military Medical Science P.L.A. China Dopamine D3 receptor ligands and preparation and medical uses of the same
NZ711583A (en) 2009-05-05 2017-03-31 Arbutus Biopharma Corp Lipid compositions

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57197265A (en) * 1981-05-29 1982-12-03 Eisai Co Ltd Carboxylic acid imide derivative, its preparation and medicament containing the same
JPS5936661A (ja) * 1982-08-26 1984-02-28 Eisai Co Ltd カルボン酸イミド誘導体およびその製造方法ならびにそれを含有する医薬
JPS5976059A (ja) * 1982-10-21 1984-04-28 Sumitomo Chem Co Ltd 環状イミド誘導体及びその酸付加塩
JPS5995267A (ja) * 1982-11-25 1984-06-01 Eisai Co Ltd カルボン酸イミド誘導体およびその製造方法
AT387773B (de) * 1983-09-12 1989-03-10 Bristol Myers Co Verfahren zur herstellung von 1-heteroaryl-4-((2,5-pyrrolidindion-1-yl)aklyl) iperazin-derivaten
US4524206A (en) * 1983-09-12 1985-06-18 Mead Johnson & Company 1-Heteroaryl-4-(2,5-pyrrolidinedion-1-yl)alkyl)piperazine derivatives
JPS60204784A (ja) 1984-03-29 1985-10-16 Eisai Co Ltd カルボン酸イミド誘導体
JP2918899B2 (ja) 1989-03-09 1999-07-12 住友製薬株式会社 環状イミド誘導体の製造方法
US5688795A (en) * 1994-11-08 1997-11-18 Syntex (U.S.A.) Inc. 3-(4-phenylpiperazin-1-yl)propyl-amino, thio and oxy!-pyridine, pyrimidine and benzene derivatives as α1 -adrenoceptor antagonists
EP0748800B1 (en) * 1995-06-09 2001-05-09 F. Hoffmann-La Roche Ag Pyrimidinedione, pyrimidinetrione, triazinedione derivatives as alpha-1-adrenergic receptor antagonists
AU6230698A (en) 1997-02-26 1998-09-18 Sumitomo Pharmaceuticals Company, Limited Dopamine d4 receptor antagonist
EA001904B1 (ru) * 1997-05-12 2001-10-22 ОРТО МакНЕЙЛ ФАРМАСЬЮТИКАЛ, ИНК. Арилзамещенные пиперазины для лечения доброкачественной гиперплазии простаты
US6083950A (en) * 1997-11-13 2000-07-04 Ranbaxy Laboratories Limited 1-(4-arylpiperazin-1-yl)-ω-[n-(α,ω-dicarboximido)]-alka nes useful as uro-selective α1-adrenoceptor blockers

Also Published As

Publication number Publication date
JP2004514711A (ja) 2004-05-20
HUP0400545A3 (en) 2007-05-02
US6914064B2 (en) 2005-07-05
EA200300620A1 (ru) 2003-12-25
AR035930A1 (es) 2004-07-28
SK8052003A3 (en) 2003-12-02
OA12537A (en) 2006-06-05
US20020156085A1 (en) 2002-10-24
PA8534001A1 (es) 2002-12-11
WO2002044151A1 (en) 2002-06-06
MA26064A1 (fr) 2004-04-01
CA2430343A1 (en) 2002-06-06
MXPA03004850A (es) 2004-01-26
ZA200304242B (en) 2004-03-02
AU2231502A (en) 2002-06-11
CZ20031698A3 (cs) 2003-11-12
NZ526226A (en) 2004-05-28
EP1339682A1 (en) 2003-09-03
KR20030068164A (ko) 2003-08-19
HUP0400545A2 (hu) 2004-07-28
EE200300250A (et) 2003-10-15
BG107943A (bg) 2004-08-31
EA006941B1 (ru) 2006-06-30
AU2002222315B2 (en) 2007-06-21
CN1486300A (zh) 2004-03-31
CN1230423C (zh) 2005-12-07
PL362210A1 (en) 2004-10-18
DOP2001000296A (es) 2003-03-15
AP2003002810A0 (en) 2003-06-30

Similar Documents

Publication Publication Date Title
BR0115865A (pt) Derivados de piperazina 1,4-di-substituìda utilizáveis como bloqueadores de receptores adrenérgicos alfa1 uro-seletivos
BR0113757A (pt) Derivados de quinolinona como inibibores de tirosina quinase
ES2194181T3 (es) Derivados de quinazolina como inhibidores de vegf.
BR0014060A (pt) Derivado de quinolil propil piperidina, processo para preparação do mesmo, e, composição farmacêutica
BR0213452A (pt) Derivados de piperazina com atividade antagonista receptora de ccr1
BRPI0412130A (pt) compostos tetracìclicos como inibidores de c-met
ES2185999T3 (es) Derivados de quinazolina y composiciones farmaceuticas que los contienen.
BR0210538A (pt) Derivados de 5-halotriptamina usados como ligantes dos receptores de serotonina 5-ht6 e/ou 5-ht7
BRPI0313942B8 (pt) derivados de benzimidazol úteis como agentes antiproliferativos, seus processos de preparação, composição farmacêutica compreendendo os mesmos e usos dos referidos compostos nas preparações de composições farmacêuticas
TR200103186T2 (tr) MEK enzimlerinin inhibitörleri olarak kinolin türevleri
BR0312232A (pt) Inibidores de caspases e seus usos
BRPI0418231A (pt) compostos de pirrolotriazina como inibidores da cinase
BR0014733A (pt) Derivados éter biarìlico úteis como inibidores de recaptação de monoamina
BR9811099A (pt) Inibidores de urocinase
BR0109211A (pt) Compostos com atividade 5-ht1a úteis para o tratamento de distúrbios da retina externa
BRPI0409255A (pt) derivados de ácido 2-(8,9-dioxo-2,6-diazabi-ciclo(5.2.0)non-1(7)-en-2-il)alquil fosfÈnico e seu uso como antagonistas de receptores de d-asparto de -n-metila (nmda)
BR0115936A (pt) 2-anilino-benzimidazóis substituìdos e sua aplicação como inibidores de nhe
BR9908470A (pt) Composto, composição farmacêutica, e, processo para tratar condições mediadas pela inegrina avb3 em um mamìfero em necessidade de tal tratamento
BR0210531A (pt) Derivados de ácido sulfÈnico
BR0012175A (pt) Antagonistas de receptor de igiur5, seletivos para o tratamento de enxaqueca
BR0310032A (pt) Derivados de benzoxazina como moduladores de 5-ht6 e usos dos mesmos
BR9908125A (pt) Composto, composto dimérico, composição farmacêutica, uso do composto, processo compreendendo inibir células de câncer, e, processo terapêutico
BR0009225A (pt) Uso de um antagonista de nmda de baixa afinidade,e, método para tratar ou prevenir a depressão emum mamìfero
BRPI0408204A (pt) derivados de quinolinona/benzoxazinona e usos dos mesmos
BR0009561A (pt) 1,4-didro indeno [1,2-c] pirazóis substituìdos como inbidores de tirosina cinase

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2021 DE 29/09/2009.